研究開発費、破産更生債権等
- 【期間】
| 年度 | 研究開発費 | 破産更生債権等 |
|---|
| 2008/03 | 370億 | | - | |
| 2009/03 | 422億 | +14.1% | 14百万 | |
| 2009/12 | 330億 | -21.8% | - | |
| 2010/03 | - | | 13百万 | -7.1% |
| 2010/12 | 384億 | +16.4% | - | |
| 2013/03 | 534億 | +39.1% | - | |
| 2013/09 | 283億 | -47% | - | |
| 2014/03 | 717億 | +153.3% | - | |
| 2014/09 | 294億 | -59% | - | |
| 2015/03 | 633億 | +115.1% | - | |
| 2015/09 | 289億 | -54.4% | - | |
| 2016/03 | 691億 | +139.2% | - | |
| 2016/09 | 285億 | -58.7% | - | |
| 2017/03 | 592億 | +107.7% | - | |
| 2017/09 | 320億 | -45.8% | - | |
| 2018/03 | 640億 | +99.7% | - | |
| 2018/09 | 347億 | -45.8% | - | |
| 2019/03 | 696億 | +100.8% | - | |
| 2019/09 | 362億 | -48% | - | |
| 2020/03 | 841億 | +132.2% | - | |
| 2020/09 | 422億 | -49.9% | - | |
| 2021/03 | 932億 | +121% | - | |
| 2021/09 | 441億 | -52.7% | - | |
| 2022/03 | 1022億 | +131.7% | - | |
| 2022/09 | 513億 | -49.8% | - | |
| 2023/03 | 1100億 | +114.4% | - | |
| 2023/09 | 594億 | -46% | - | |
